104 related articles for article (PubMed ID: 2063780)
1. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels.
Ginsburg GS; Safran C; Pasternak RC
Am J Cardiol; 1991 Jul; 68(2):187-92. PubMed ID: 2063780
[TBL] [Abstract][Full Text] [Related]
2. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease.
Drexel H; Amann FW; Rentsch K; Neuenschwander C; Luethy A; Khan SI; Follath F
Am J Cardiol; 1992 Aug; 70(4):436-40. PubMed ID: 1642180
[TBL] [Abstract][Full Text] [Related]
3. Range of serum cholesterol values in the population developing coronary artery disease.
Kannel WB
Am J Cardiol; 1995 Sep; 76(9):69C-77C. PubMed ID: 7572691
[TBL] [Abstract][Full Text] [Related]
4. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.
Miller M; Mead LA; Kwiterovich PO; Pearson TA
Am J Cardiol; 1990 Jan; 65(1):1-5. PubMed ID: 2294675
[TBL] [Abstract][Full Text] [Related]
6. Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension.
French JK; Elliott JM; Williams BF; Nixon DJ; Denton MA; White HD
Am J Cardiol; 1993 Mar; 71(7):505-10. PubMed ID: 8438734
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women.
Hong MK; Romm PA; Reagan K; Green CE; Rackley CE
Am J Cardiol; 1991 Dec; 68(17):1646-50. PubMed ID: 1746467
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride levels and the risk of coronary artery disease: a view from Australia.
Simons LA
Am J Cardiol; 1992 Dec; 70(19):14H-18H. PubMed ID: 1466312
[TBL] [Abstract][Full Text] [Related]
10. High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease.
Nikkilä M; Koivula T; Niemelä K; Sisto T
Br Heart J; 1990 Feb; 63(2):78-81. PubMed ID: 2317412
[TBL] [Abstract][Full Text] [Related]
11. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease.
Romm PA; Green CE; Reagan K; Rackley CE
Am J Cardiol; 1991 Mar; 67(6):479-83. PubMed ID: 1671804
[TBL] [Abstract][Full Text] [Related]
12. Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.
Miller M; Seidler A; Kwiterovich PO; Pearson TA
Circulation; 1992 Oct; 86(4):1165-70. PubMed ID: 1394924
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.
Krumholz HM; Seeman TE; Merrill SS; Mendes de Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Berkman LF
JAMA; 1994 Nov; 272(17):1335-40. PubMed ID: 7772105
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
[TBL] [Abstract][Full Text] [Related]
16. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
17. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
[TBL] [Abstract][Full Text] [Related]
18. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
20. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group.
Rubins HB; Robins SJ; Collins D; Iranmanesh A; Wilt TJ; Mann D; Mayo-Smith M; Faas FH; Elam MB; Rutan GH
Am J Cardiol; 1995 Jun; 75(17):1196-201. PubMed ID: 7778538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
